Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 发行人是于2015年4月30日由杭州泰林生物技术设备有限公司整体变更设立的股份有限公司,注册资本为3,897万元。 发行人主营业务为微生物检测与控制技术系统产品、有机物分析仪器等制药装备的研发、制造和销售,具体产品包括各类耗材、仪器和设备,可单独或组合应用于无菌药品的生产和质量检测,同时可以拓展的应用领域包括医疗卫生、食品安全、疾病防控、生物安全、检验检疫、生物工程、实验动物和环境保护等大健康产业。公司客户包括华润双鹤(600062)、科伦药业(002422)、扬子江药业、上海医药(601607)、哈药股份(600664)、国药集团、勃林格殷格翰、药明康德(603259)、恒瑞医药(600276)、云南白药(000538)等综合实力强大的大型制药企业,优良的客户基础为经营业绩的持续快速增长提供了保障。 公司是国内最早针对现代微生物检测方法研制和生产微生物检测仪器与培养器耗材的企业,促进《中国药典》修订了“1101无菌检查法”、“1105、1106非无菌产品微生物限度检查”的技术与操作标准,面向制药行业推广了全封闭微生物检测系统在注射制剂无菌检查及开放式微生物检测系统在口服及外用制剂微生物限度检查领域的应用;同时,根据微生物检测操作所需的空间隔离与环境控制要求,公司进一步研制开发了国内首台无菌隔离器和VHP灭菌器,促进《中国药典》增订了“9206无菌检查用隔离系统验证指导原则”,并同步开发了上述各类仪器、设备的嵌入式软件和操作系统,取得了21软件著作权。 通过上述硬件创新、软件开发及技术标准对接,公司在国内率先打造了全产品系列的现代微生物检测与控制技术系统,具体由微生物检测技术系列、隔离技术系列和灭菌技术系列等三个产品系列组成。各系列的具体产品一方面可用于构建一个有机结合、完整统一的微生物检测与控制技术系统,针对制药、食品安全、医疗卫生、疾病预防与控制、检验检疫等领域的需求,提供从空间环境灭菌、无菌隔离、无菌传递等无菌环境控制到微生物检测与分析的完整解决方案,从而替代传统的无菌和微生物实验室;另一方面还可独立应用于医疗卫生、食品安全、疾病防控、生物安全、检验检疫、生物工程、实验动物和环境保护等大健康领域,具有广阔的市场空间和良好的应用前景。 同时,围绕制药企业客户对于制药用水中的有机物检测与分析需求,公司促进《中国药典》增订了制药用水总有机碳标准,并结合相关技术标准研制了以TOC分析仪为代表的有机物分析技术系列产品,同步开发了TOC分析仪的的数据处理、检测分析、取样控制等软件和操作系统,取得了6项软件著作权;公司生产的TOC分析仪在超纯水、制药用水、天然水体饮用水、环保污水、化工工艺用水的水质分析与检测等领域具有良好的应用前景。 作为高新技术企业,公司曾参与制定20项国家标准和行业标准,其中12项为第一作者,多项产品技术促进了《中国药典》相关标准的修订和增订;目前,公司拥有200项专利,其中发明专利16项,承担了“高性能智能化无菌检测仪的开发和应用”、“高等级病原微生物实验室生物安全防护技术与产品研究”和“劳动密集型洁净厂房职业病危害防护技术与装备研发”等三个“十三五国家科技创新规划--国家重点研发计划”项目,分别担任其中的项目牵头承担单位、子项目参与单位和关键装备研发单位。 | ||||||||||||||||||||||||
Main Business | 微生物检测系统、环境生物污染控制装备及总有机碳分析仪器等产品的研发、生产和销售。 | ||||||||||||||||||||||||
Legal Representative | 叶大林 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 叶星月 | ||||||||||||||||||||||||
Solicitors | 上海市锦天城律师事务所 | ||||||||||||||||||||||||
Auditors | 天健会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0571-86589069 | ||||||||||||||||||||||||
Fax No | 0571-86689998 | ||||||||||||||||||||||||
Website | www.tailingood.com | ||||||||||||||||||||||||
tailin@tailingood.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 14/01/2020 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.180 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.100 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 5.970 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 1.344B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |